Intrarosa receives approval to treat women experiencing pain during sex
by Press Release from Outbreak News Today on (#22329)
The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA). During menopause, levels of ["]
The post Intrarosa receives approval to treat women experiencing pain during sex appeared first on Outbreak News Today.